PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1955074
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1955074
The global autorefractor and keratometer market was valued at USD 73.26 million in 2025 and is projected to grow from USD 77.1 million in 2026 to USD 120.19 million by 2034, registering a CAGR of 5.71% during the forecast period. North America dominated the market in 2025, supported by advanced healthcare infrastructure and strong adoption of ophthalmic diagnostic technologies.
Autorefractors and keratometers are essential ophthalmic instruments used to measure refractive errors and corneal curvature. An autorefractor evaluates how light changes as it enters the eye to determine refractive error, while a keratometer measures the curvature of the cornea. Hybrid devices, commonly known as autorefractor-keratometers (ARKs), combine both functions, offering comprehensive eye assessments in a single system.
The rising burden of ocular disorders such as hyperopia, myopia, astigmatism, cataracts, and diabetic retinopathy is significantly driving demand for advanced diagnostic equipment worldwide. Key players operating in the market include Topcon Corporation, NIDEK CO., LTD., Carl Zeiss Meditech AG, EssilorLuxottica, and CANON MEDICAL SYSTEMS CORPORATION.
Market Drivers
Rising Prevalence of Ocular Diseases
Increasing incidence of vision disorders is a major growth driver. Lifestyle changes, rising screen time, an aging population, and growing diabetic cases are contributing to higher rates of refractive errors. According to global studies, myopia cases are projected to affect nearly half of the world's population by 2050.
Governments and healthcare organizations are emphasizing early diagnosis and preventive eye care. Regular eye screening initiatives and awareness programs are increasing the utilization of autorefractors and keratometers in hospitals and clinics, thereby supporting steady market expansion.
Market Restraints
Limited Awareness and High Device Costs
Despite technological advancements, limited awareness of routine eye examinations in low- and middle-income countries restrains market growth. Additionally, high-end autorefractor models can cost over USD 25,000, making them less accessible for smaller healthcare facilities.
Affordability concerns and delayed diagnosis due to lack of awareness may limit device penetration, especially in resource-constrained regions.
Market Opportunities
Strategic Partnerships and Technological Innovation
Rising collaborations, mergers, and acquisitions among key players are creating growth opportunities. Companies are investing in R&D to develop portable and AI-integrated diagnostic devices.
For instance, Carl Zeiss Meditech AG strengthened its ophthalmic portfolio through acquisitions aimed at enhancing digital workflow and advanced diagnostics. Increasing innovation in handheld and automated devices is expected to expand product adoption across developed and emerging markets.
Market Challenges
Shortage of Skilled Ophthalmic Professionals
A shortage of trained ophthalmic technicians and specialists presents a key challenge. Workforce imbalance limits the effective utilization of advanced diagnostic equipment, particularly in rural and underserved regions. This may reduce patient access to timely eye diagnosis and treatment.
Market Trends
Integration of AI and Digital Technologies
Technological advancements are reshaping the diagnostic landscape. Modern autorefractors and keratometers now feature digital displays, automated focusing, high-resolution imaging, cloud integration, and electronic health record (EHR) compatibility.
The integration of artificial intelligence (AI) and machine learning (ML) enables real-time analytics and precision diagnostics. These innovations improve accuracy in detecting cataracts, keratoconus, and subtle corneal abnormalities, boosting adoption across ophthalmic practices.
Impact of COVID-19
The COVID-19 pandemic negatively impacted market growth due to reduced patient visits and postponed elective examinations. Several companies experienced revenue declines in 2020. However, with the resumption of healthcare services in 2021, patient visits recovered, and the market gradually returned to its pre-pandemic growth trajectory.
By Product Type
The market is segmented into autorefractor, keratometer, and hybrid devices.
The hybrid segment (ARKs) is expected to hold a dominant share due to its high accuracy and dual-function capability. The autorefractor segment is projected to witness steady growth with AI-enabled enhancements.
By Portability
Based on portability, the market is divided into tabletop and handheld devices.
The tabletop segment dominates due to its widespread use in optometric offices and hospitals. The handheld segment is growing rapidly, driven by demand for portable diagnostic solutions in mobile clinics and rural outreach programs.
By Indication
The market includes hyperopia, myopia, astigmatism, and others.
The hyperopia segment held a significant share in 2024 due to its rising prevalence among adults and children. Myopia is projected to grow steadily due to increasing digital device usage.
By End-user
The market is segmented into hospitals, ophthalmic clinics, and others.
Hospitals dominated in 2024 due to higher patient volume and access to advanced equipment. Ophthalmic clinics are expected to grow at the fastest CAGR due to increasing specialized eye care centers.
North America
North America dominated the market in 2025, with a value of USD 26.65 million. Strong reimbursement policies, rising diabetic cases, and advanced healthcare infrastructure are key growth drivers.
Europe
Europe holds a substantial share due to strict medical device regulations and a large ophthalmologist base, supporting higher diagnostic rates.
Asia Pacific
Asia Pacific is projected to grow at the fastest CAGR due to rising healthcare investments and a large patient pool in countries such as China, India, and Japan.
Latin America & Middle East & Africa
These regions are witnessing moderate growth, supported by improving healthcare infrastructure and increasing government investments.
Competitive Landscape
The market is consolidated, with leading players such as Carl Zeiss Meditech AG, Topcon Corporation, and NIDEK CO., LTD. focusing on product innovation, partnerships, and geographic expansion. Companies are emphasizing AI integration, portability, and digital connectivity to gain a competitive edge.
Conclusion
The global autorefractor and keratometer market is expected to grow steadily from USD 73.26 million in 2025 to USD 120.19 million by 2034, driven by the rising prevalence of ocular diseases, technological advancements, and increasing emphasis on early diagnosis. While high device costs and workforce shortages present challenges, expanding healthcare infrastructure, AI-enabled innovations, and growing awareness of preventive eye care will support long-term market expansion worldwide.
Segmentation By Product Type
By Portability
By Indication
By End-user
By Region